[HTML][HTML] EZH2: a novel target for cancer treatment
R Duan, W Du, W Guo - Journal of hematology & oncology, 2020 - Springer
Enhancer of zeste homolog 2 (EZH2) is enzymatic catalytic subunit of polycomb repressive
complex 2 (PRC2) that can alter downstream target genes expression by trimethylation of …
complex 2 (PRC2) that can alter downstream target genes expression by trimethylation of …
EZH2: a novel target for cancer treatment
R Duan, W Du, W Guo - Journal of hematology & oncology, 2020 - pubmed.ncbi.nlm.nih.gov
Enhancer of zeste homolog 2 (EZH2) is enzymatic catalytic subunit of polycomb repressive
complex 2 (PRC2) that can alter downstream target genes expression by trimethylation of …
complex 2 (PRC2) that can alter downstream target genes expression by trimethylation of …
EZH2: a novel target for cancer treatment.
R Duan, W Du, W Guo - Journal of Hematology & Oncology, 2020 - go.gale.com
Enhancer of zeste homolog 2 (EZH2) is enzymatic catalytic subunit of polycomb repressive
complex 2 (PRC2) that can alter downstream target genes expression by trimethylation of …
complex 2 (PRC2) that can alter downstream target genes expression by trimethylation of …
EZH2: a novel target for cancer treatment.
R Duan, W Du, W Guo - Journal of Hematology & Oncology, 2020 - search.ebscohost.com
Enhancer of zeste homolog 2 (EZH2) is enzymatic catalytic subunit of polycomb repressive
complex 2 (PRC2) that can alter downstream target genes expression by trimethylation of …
complex 2 (PRC2) that can alter downstream target genes expression by trimethylation of …
[HTML][HTML] EZH2: a novel target for cancer treatment
R Duan, W Du, W Guo - Journal of Hematology & …, 2020 - jhoonline.biomedcentral.com
Enhancer of zeste homolog 2 (EZH2) is enzymatic catalytic subunit of polycomb repressive
complex 2 (PRC2) that can alter downstream target genes expression by trimethylation of …
complex 2 (PRC2) that can alter downstream target genes expression by trimethylation of …
[HTML][HTML] EZH2: a novel target for cancer treatment
R Duan, W Du, W Guo - Journal of Hematology & Oncology, 2020 - ncbi.nlm.nih.gov
Enhancer of zeste homolog 2 (EZH2) is enzymatic catalytic subunit of polycomb repressive
complex 2 (PRC2) that can alter downstream target genes expression by trimethylation of …
complex 2 (PRC2) that can alter downstream target genes expression by trimethylation of …
[引用][C] EZH2: a novel target for cancer treatment
R Duan, W Guo - Journal of Hematology & Oncology (Web), 2020 - jglobal.jst.go.jp
EZH2: a novel target for cancer treatment | Article Information | J-GLOBAL Art J-GLOBAL ID:202102260510725894
Reference number:21A0099019 EZH2: a novel target for cancer treatment EZH2:癌治療の …
Reference number:21A0099019 EZH2: a novel target for cancer treatment EZH2:癌治療の …
EZH2: a novel target for cancer treatment
R Duan, W Du, W Guo - Journal of Hematology & Oncology, 2020 - search.proquest.com
Enhancer of zeste homolog 2 (EZH2) is enzymatic catalytic subunit of polycomb repressive
complex 2 (PRC2) that can alter downstream target genes expression by trimethylation of …
complex 2 (PRC2) that can alter downstream target genes expression by trimethylation of …
EZH2: a novel target for cancer treatment
R Duan, W Du, W Guo - Journal of Hematology & Oncology, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Enhancer of zeste homolog 2 (EZH2) is
enzymatic catalytic subunit of polycomb repressive complex 2 (PRC2) that can alter …
enzymatic catalytic subunit of polycomb repressive complex 2 (PRC2) that can alter …
EZH2: a novel target for cancer treatment.
R Duan, W Du, W Guo - Journal of Hematology & Oncology, 2020 - europepmc.org
Enhancer of zeste homolog 2 (EZH2) is enzymatic catalytic subunit of polycomb repressive
complex 2 (PRC2) that can alter downstream target genes expression by trimethylation of …
complex 2 (PRC2) that can alter downstream target genes expression by trimethylation of …